Koyfin Home > Directory > Health Care > Adamas Pharma > Issuance of Common Stock

Adamas Pharma Issuance of Common Stock Chart (ADMS)

Adamas Pharma annual/quarterly Issuance of Common Stock from 2012 to 2020.
  • Adamas Pharma Issuance of Common Stock for the quarter ending June 06, 2020 was $0m a 40.36% increase of 0m year over year
  • Adamas Pharma Issuance of Common Stock for the last 12 months ending June 06, 2020 was $1m a -55.84% decrease of 0m year over year
  • Adamas Pharma Annual Issuance of Common Stock for 2019 was $1m a -12,697.24% decrease of -138m from 2018
  • Adamas Pharma Annual Issuance of Common Stock for 2018 was $139m a 92.89% increase of 129m from 2017
  • Adamas Pharma Annual Issuance of Common Stock for 2017 was $10m a -562.29% decrease of -56m from 2016
Other Cash Flow Metrics:
  • Adamas Pharma Cash Flow from Operations for the quarter ending December 12, 2018 was $-24m a -5.06% increase of 1m year over year
  • Adamas Pharma Levered Free Cash Flow (FCF) for the quarter ending December 12, 2018 was $-33m a 50.48% decrease of -17m year over year
  • Adamas Pharma Total Revenue for the quarter ending September 09, 2018 was $11m a 94.65% increase of 10m year over year
View Chart On Koyfin

Quarterly ADMS Issuance of Common Stock Data

06/2020$0m
03/2020$0m
12/2019$0m
09/2019$0m
06/2019$1m
03/2019$0m
12/2018$0m
09/2018$1m
06/2018$2m
03/2018$135m

Annual ADMS Issuance of Common Stock Data

2019$1m
2018$139m
2017$10m
2016$65m
2015$11m
2014$46m
2013$0m
2012$4m